○Noriko Komatsu Komatsu¹, Hiroshi Takayanagi¹ (1. Department of Immunology Graduate School of Medicine and Faculty of Medicine The University of Tokyo)

○Sayuki Iwahashi¹, Takuya Kadota², Kazuya Fukasawa¹, Takashi Iezaki¹, Hiroaki Shirahase², Tatsuya Kitao², Eiichi Hinoi¹ (1. Lab. Pharmacol., Dept. Bioactive Molecules, Gifu Pharmaceut. Univ., 2. Drug Discovery Res. Dept., Kyoto Pharmaceut. Ind.)

○Yasuka Okayama¹, Shinsuke Ochiai¹, Tetsuhiro Horie¹, Takashi Iezaki¹, kazuya Fukasawa¹, Masaki Kamakura², Kumiko Ikeno³, Katashi Nagamatsu⁴, Eiichi Hinoi¹ (1. Gifu Pharmaceutical Univ., 2. Faculty of Engineering, Toyama Prefectural Univ., 3. Akitaya Honten, 4. R&D Division, MORIKAWA KENKODO)

○Aoi Koyama¹, Hiroto Kobayashi¹, Tomonori Inoue¹, Mitio Yamashita¹, Takahiro Hirabayashi², Inkwan HWANG³, Tetsuro Kobayashi³, Yoshihiko Chiba¹, Seiji Shioda², Fumiko Takenoya¹ (1. Hoshi University, 2. Shonan University of Medical Sciences, 3. Nippon sport Science University)